Halozyme Therapeutics HALO
NASDAQ HALO
$106.94 -3.46 (-3.13%)
At close: Oct 1, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Change in Receivables (2010 - 2026)

Updated

Halozyme Therapeutics' Change in Receivables was -$2.16 million in Q2 2026, compared with $11.72 million a year earlier.

Analysis

Halozyme Therapeutics (HALO) Change in Receivables (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Halozyme Therapeutics' Change in Receivables was $137.56 million through Jun 30, 2026, up 35.1% year-over-year; for FY2025, it came in at $128.06 million, up 72.5% from FY2024.

  • Change in Receivables shows a five-year compound annual growth rate of 27.3% (FY2020 to FY2025).
  • In earlier years, Change in Receivables was $74.25 million in FY2024, $3.34 million in FY2023 (-96.0%), $83.94 million in FY2022 and -$6.76 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Change in Receivables since Q1 2025.
  • Compared with a year earlier, Change in Receivables was higher in two of the last four quarters, with growth averaging 59.4%.
  • The best year-over-year quarter for Change in Receivables over five years was Q2 2023 (growth of 444.1%); the worst was Q2 2022 (a decline of 85.4%).
  • Per Business Quant data, HALO's Change in Receivables in the three quarters before Q2 2026 was $19.55 million (Q1 2026), $90.48 million (Q4 2025) and $29.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn -2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.16 Mn
Mar 31, 2026 19.55 Mn
Dec 31, 2025 90.48 Mn
Sep 30, 2025 29.70 Mn
Jun 30, 2025 11.72 Mn
Mar 31, 2025 -3.83 Mn
Dec 31, 2024 22.71 Mn
Sep 30, 2024 71.22 Mn
Jun 30, 2024 18.62 Mn
Mar 31, 2024 -38.31 Mn
Dec 31, 2023 16.89 Mn
Sep 30, 2023 -28.85 Mn
Jun 30, 2023 51.50 Mn
Mar 31, 2023 -36.19 Mn
Dec 31, 2022 7.76 Mn
Sep 30, 2022 43.93 Mn
Jun 30, 2022 9.47 Mn
Mar 31, 2022 22.79 Mn
Dec 31, 2021 -21.12 Mn
Sep 30, 2021 -41.10 Mn
API Access

Halozyme Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=HALO&period=max&api_key=YOUR_API_KEY